equivalent to -59.59 % and – 14.81 % net profit margin of 2017 and 2016, respectively. The loss was higher than last year due to the reduction of the company’ s total income and the increase of the

: EIC-AD008/2019 February 27, 2019 Subject: Management Discussion and Analysis Yearly Financial Period Ending 31 December 2018 To: President The Stock Exchange of Thailand The Board of Directors of

1 Ref: CK-18-0000-AFD(AC)-L-0022 May 15, 2018 Subject: Clarification on Operating Result and Financial Position for the three-month ended March 31, 2018 Attention: President The Stock Exchange of

Attention: President The Stock Exchange of Thailand Regarding to JAS Asset Public Company Limited (“the Company”) Board of Meeting No.4/2020 on 15 May 2020, the resolution to certify the Company’s financial

EKH/CS/2020/030 11 August 2020 Subject: Management Discussion and Analysis for the Second Quarter 2020 results To Directors and Manager The Stock Exchange of Thailand Ekachai Medical Care Public

(Ending March 31, 2020) To Director and Manager of the Stock Exchange of Thailand Ubis (Asia) Public Company Limited (“the Company”) would like to clarify on the performance and the financial status for the

president, The Stock Exchange of Thailand. Demco Public Company Limited would like to inform you herewith the company result of the 3rd quaternary for the year 2017 according to the company’s financial

-9320 1 Ref: PLC 2017/017 November 16, 2017 Subject: Management Discussion and Analysis Quarter 3 Ended 30-September-2017 (Additional) To: The President of the Stock Exchange of Thailand Panjawattana

วันที่ 14 สิงหาคม 2550 DEMCO Public Company Limited No. Demco AC002/2018 February 28, 2018 Subject : The company’s operating result of the year 2017. To : The president, The Stock Exchange of

วันที่ 14 สิงหาคม 2550 DEMCO Public Company Limited No. Demco AC001/2019 February 28, 2019 Subject : The company’s operating result of the year 2018 To : The president, The Stock Exchange of Thailand